Popular stocks with increasing volume: MRK NVDA PTON DKNG MRNA PENN AAL

Go back to Popular stocks with increasing volume: MRK NVDA PTON DKNG MRNA PENN AAL

Merck (MRK) and Ridgeback Announce Additional Purchase of 1.4M Courses of Molnupiravir by the US Government

November 9, 2021 6:04 AM EST

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United States government will exercise two of its options to purchase a total of 1.4 million additional courses of molnupiravir, an investigational oral antiviral medicine, if the medicine is granted Emergency Use Authorization (EUA) or approval by the U.S. Food and Drug Administration (FDA), for approximately $1 billion. With these exercised options, the U.S. government has now committed to purchase a total of approximately 3.1 million courses of molnupiravir, for approximately $2.2 billion, between authorization and... More

Merck (MRK) ahead of Pfizer (PFE) in EU talks on COVID-19 pills -EU source - Reuters

November 8, 2021 11:15 AM EST

Merck (NYSE: MRK) ahead of Pfizer (NYSE: PFE) in EU talks on COVID-19 pills -EU source - Reuters

... More